The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 first-in-human (FIH) dose-escalation (DE) study of the oral dual PI3K/mTOR inhibitor PQR309 in patients (pts) with advanced solid tumors: Final DE results.
 
Rebecca Sophie Kristeleit
Honoraria - Clovis Oncology; Novartis; Roche/Genentech
Consulting or Advisory Role - Clovis Oncology; Novartis
Travel, Accommodations, Expenses - Basilea; Clovis Oncology; PiQuR
 
Nicholas F. Brown
No Relationships to Disclose
 
Dagmar Hess
No Relationships to Disclose
 
Markus Joerger
No Relationships to Disclose
 
Roger Von Moos
No Relationships to Disclose
 
Jordi Rodón
No Relationships to Disclose
 
Cinta Hierro
No Relationships to Disclose
 
Alexa Childs
No Relationships to Disclose
 
Anastasios Stathis
No Relationships to Disclose
 
Sasa Dimitrijevic
Employment - PIQUR
Leadership - PIQUR
Stock and Other Ownership Interests - PIQUR
 
Michael Stumm
Employment - PIQUR
Leadership - PIQUR
Stock and Other Ownership Interests - PIQUR
 
Richard Herrmann
Employment - PIQUR
Leadership - PIQUR
Stock and Other Ownership Interests - PIQUR
Honoraria - PIQUR
Consulting or Advisory Role - PIQUR
 
Cristiana Sessa
No Relationships to Disclose
 
Vincent Bize
No Relationships to Disclose
 
Viviane Hess
No Relationships to Disclose
 
Andreas Wicki
No Relationships to Disclose